When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Prevention of dementia - Wikipedia

   en.wikipedia.org/wiki/Prevention_of_dementia

   The prevention of dementia involves reducing the number of risk factors for the development of dementia, and is a global health priority needing a global response. [1] [2] Initiatives include the establishment of the International Research Network on Dementia Prevention (IRNDP) [3] which aims to link researchers in this field globally, and the establishment of the Global Dementia Observatory ...

3. Psychological therapies for dementia - Wikipedia

   en.wikipedia.org/wiki/Psychological_therapies...

   Psychological therapies for dementia are starting to gain some momentum. [when?] Improved clinical assessment in early stages of Alzheimer's disease and other forms of dementia, increased cognitive stimulation of the elderly, and the prescription of drugs to slow cognitive decline have resulted in increased detection in the early stages.

4. Alzheimer's disease - Wikipedia

   en.wikipedia.org/wiki/Alzheimer's_disease

   Alzheimer's disease (AD) is a neurodegenerative disease that usually starts slowly and progressively worsens. [2] It is the cause of 60–70% of cases of dementia. [2] [15] The most common early symptom is difficulty in remembering recent events. [1]

5. SMART criteria - Wikipedia

   en.wikipedia.org/wiki/SMART_criteria

   S.M.A.R.T. (or SMART) is an acronym used as a mnemonic device to establish criteria for effective goal-setting and objective development. This framework is commonly applied in various fields, including project management, employee performance management, and personal development.

6. National Alzheimer's Project Act - Wikipedia

   en.wikipedia.org/wiki/National_Alzheimer's...

   The National Alzheimer's Project Act recommended $2 billion a year to achieve their goal of preventing and treating Alzheimer's disease by 2025. In 2017, a bill was approved to boost government funding for Alzheimer's disease to almost $1.4 billion for the fiscal year. [7]

7. Lilly Alzheimer's drug gets unanimous backing from FDA ... - AOL

   www.aol.com/news/us-fda-advisers-review-eli...

   A key difference in trial design for the two treatments is that Lilly measured levels of a second Alzheimer's-related protein called tau associated with brain cell death to select patients most ...